Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD

Clinical trial NCT02444637 · COMPLETED

Trial details

NCT number: NCT02444637
Sponsor: National Neuroscience Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer Disease CVA (Cerebrovascular Accident)

Start date: 2015-04-01
Primary completion: 2019-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.